Rachel Fisher

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Rachel Fisher är professor i kardiovaskulära sjukdomar vid Karolinska Institutet sedan 2009. Hennes forskning handlar om de molekylära mekanismerna bakom störd fettomsättning och hur det bidrar till bland annat hjärt-kärlsjukdom och typ 2-diabetes.

Artiklar

Article: JOURNAL OF PLASTIC, RECONSTRUCTIVE AND AESTHETIC SURGERY. 2023;76:18-26
Capsular inflammation after immediate breast reconstruction-Gene expression patterns and inflammatory cell infiltration in irradiated and non-irradiated breasts
Frisell A; Bergman O; Khan A; Gistera A; Fisher RM; Lagergren J; de Boniface J; Halle M
Article: JOURNAL OF PHYSIOLOGY. 2022;600(4):869-883
Hypertrophied human adipocyte spheroids as in vitro model of weight gain and adipose tissue dysfunction
Ioannidou A; Alatar S; Schipper R; Baganha F; Ahlander M; Hornell A; Fisher RM; Hagberg CE
Article: JOURNAL OF LIPID RESEARCH. 2019;60(6):1069-1077
PNPLA2 influences secretion of triglyceride-rich lipoproteins by human hepatoma cells
Taxiarchis A; Mahdessian H; Silveira A; Fisher RM; van't Hooft FM
Article: KIDNEY INTERNATIONAL REPORTS. 2017;2(6):1208-1218
Altered Protein Composition of Subcutaneous Adipose Tissue in Chronic Kidney Disease
Gertow J; Ng CZ; Branca RMM; Werngren O; Du L; Kjellqvist S; Hemmingsson P; Bruchfeld A; MacLaughlin H; Eriksson P; Axelsson J; Fisher RM
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2016;36(6):1132-1140
Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation
Edsfeldt A; Duner P; Stahlman M; Mollet IG; Asciutto G; Grufman H; Nitulescu M; Persson AF; Fisher RM; Melander O; Orho-Melander M; Boren J; Nilsson J; Goncalves I
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2016;136(3):640-648
Psoriasis Skin Inflammation-Induced microRNA-26b Targets NCEH1 in Underlying Subcutaneous Adipose Tissue
Cheung L; Fisher RM; Kuzmina N; Li D; Li X; Werngren O; Blomqvist L; Stahle M; Landen NX
Article: BRITISH JOURNAL OF SPORTS MEDICINE. 2014;48(19):1407-1409
Stand up for health-avoiding sedentary behaviour might lengthen your telomeres: secondary outcomes from a physical activity RCT in older people
Sjogren P; Fisher R; Kallings L; Svenson U; Roos G; Hellenius M-L
Article: NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES. 2014;24(2):124-131
Ceramides are associated with inflammatory processes in human mediastinal adipose tissue
Gertow J; Kjellqvist S; Stahlman M; Cheung L; Gottfries J; Werngren O; Boren J; Franco-Cereceda A; Eriksson P; Fisher RM
Article: NUTRITION & DIABETES. 2013;3(5):e66
Human mediastinal adipose tissue displays certain characteristics of brown fat
Cheung L; Gertow J; Werngren O; Folkersen L; Petrovic N; Nedergaard J; Franco-Cereceda A; Eriksson P; Fisher RM
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2013;31(5):1003-1010
MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor δ in human monocytes during the inflammatory response
Thulin P; Wei T; Werngren O; Cheung L; Fisher RM; Grander D; Corcoran M; Ehrenborg E
Article: LIPIDS IN HEALTH AND DISEASE. 2012;11:115
Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue
Kolak M; Gertow J; Westerbacka J; Summers SA; Liska J; Franco-Cereceda A; Oresic M; Yki-Jarvinen H; Eriksson P; Fisher RM
Article: LIPIDS IN HEALTH AND DISEASE. 2012;11:80
Functional changes in adipose tissue in a randomised controlled trial of physical activity
Sjogren P; Sierra-Johnson J; Kallings LV; Cederholm T; Kolak M; Halldin M; Brismar K; de Faire U; Hellenius M-L; Fisher RM
Article: THE FASEB JOURNAL. 2010;24(11):4366-4377
Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity
Zadravec D; Brolinson A; Fisher RM; Carneheim C; Csikasz RI; Bertrand-Michel J; Boren J; Guillou H; Rudling M; Jacobsson A
Article: AMERICAN JOURNAL OF PHYSIOLOGY - ENDOCRINOLOGY AND METABOLISM. 2010;299(2):E234-E240
Systemic inflammation activates the nuclear factor-κB regulatory pathway in adipose tissue
Ekstrom M; Halle M; Bjessmo S; Liska J; Kolak M; Fisher R; Eriksson P; Tornvall P
Article: EUROPEAN HEART JOURNAL. 2010;30(6):710-717
Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population
Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius M-L; Hamsten A
Article: DIABETOLOGIA. 2009;52(6):1056-1060
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans
Kotronen A; Johansson LE; Johansson LM; Roos C; Westerbacka J; Hamsten A; Bergholm R; Arkkila P; Arola J; Kiviluoto T; Fisher RM; Ehrenborg E; Orho-Melander M; Ridderstrale M; Groop L; Yki-Jarvinen H
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY (EJE). 2009;160(4):593-602
Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts
Kotronen A; Yki-Jarvinen H; Aminoff A; Bergholm R; Pietilainen KH; Westerbacka J; Talmud PJ; Humphries SE; Hamsten A; Isomaa B; Groop L; Orho-Melander M; Ehrenborg E; Fisher RM
Article: CLINICAL SCIENCE. 2009;116(5-6):507-512
IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Malarstig A; Brismar K; Hamsten A; Fisher RM; Hellenius M-L
Article: EUROPEAN HEART JOURNAL. 2008;29(18):2218-2226
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction
Sjogren P; Fredrikson GN; Samnegard A; Ericsson C-G; Ohrvik J; Fisher RM; Nilsson J; Hamsten A
Article: OBESITY. 2008;16(6):1302-1307
Eating meals irregularly:: A novel environmental risk factor for the metabolic syndrome
Sierra-Johnson J; Unden A-L; Linestrand M; Rosell M; Sjogren P; Kolak M; De Faire U; Fisher RM; Hellenius M-L
Article: AMERICAN JOURNAL OF PHYSIOLOGY - GASTROINTESTINAL AND LIVER PHYSIOLOGY. 2008;294(5):G1281-G1287
Gene expression in human NAFLD
Greco D; Kotronen A; Westerbacka J; Puig O; Arkkila P; Kiviluoto T; Laitinen S; Kolak M; Fisher RM; Hamsten A; Auvinen P; Yki-Jarvinen H
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2008;93(5):1995-2001
Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation
Krapivner S; Popov S; Chernogubova E; Hellenius M-L; Fisher RM; Hamsten A; van't Hooft FM
Article: AMERICAN JOURNAL OF PHYSIOLOGY - ENDOCRINOLOGY AND METABOLISM. 2008;294(5):E841-E845
Insulin regulation of MCP-1 in human adipose tissue of obese and lean women
Westerbacka J; Corner A; Kolak M; Makkonen J; Turpeinen U; Hamsten A; Fisher RM; Yki-Jarvinen H
Article: METABOLISM: CLINICAL AND EXPERIMENTAL. 2008;57(3):362-366
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men
Sjogren P; Fredrikson GN; Rosell M; de Faire U; Hamsten A; Nilsson J; Hellenius M-L; Fisher RM
Article: DIABETOLOGIA. 2008;51(2):328-335
Fatty acid desaturases in human adipose tissue:: relationships between gene expression, desaturation indexes and insulin resistance
Sjogren P; Sierra-Johnson J; Gertow K; Rosell M; Vessby B; de Faire U; Hamsten A; Hellenius M-L; Fisher RM
Article: ATHEROSCLEROSIS. 2007;195(2):e168-e175
Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product Nε-carboxymethyl-lysine in healthy Swedish men
Sjogren P; Basta G; de Caterina R; Rosell M; Basu S; Silveira A; de Faire U; Vessby B; Hamsten A; Hellenius M-L; Fisher RM
Article: EUROPEAN HEART JOURNAL. 2007;28(21):2637-2643
ApoB/apoA-1 ratio:: an independent predictor of insulin resistance in US non-diabetic subjects
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellenius M-L; Fisher RM
Article: DIABETES. 2007;56(11):2759-2765
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects
Westerbacka J; Kolak M; Kiviluoto T; Arkkila P; Siren J; Hamsten A; Fisher RM; Yki-Jaervinen H
Article: INTERNATIONAL JOURNAL OF OBESITY. 2007;31(10):1617-1625
Increased expression of the macrophage markers and of 11β-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity
Makkonen J; Westerbacka J; Kolak M; Sutinen J; Corner A; Hamsten A; Fisher RM; Yki-Jarvinen H
Article: DIABETES. 2007;56(8):1960-1968
Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity
Kolak M; Westerbacka J; Velagapudi VR; Wagsater D; Yetukuri L; Makkonen J; Rissanen A; Hakkinen A-M; Lindell M; Bergholm R; Hamsten A; Eriksson P; Fisher RM; Oresic M; Yki-Jarvinen H
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2007;92(2):720-724
Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes
Kolak M; Yki-Jarvinen H; Kannisto K; Tiikkainen M; Hamsten A; Eriksson P; Fisher RM
Article: EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2006;60(12):1406-1413
Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance
Gertow K; Rosell M; Sjogren P; Eriksson P; Vessby B; de Faire U; Hamsten A; Hellenius M-L; Fisher RM
Article: DIABETOLOGIA. 2006;49(1):132-140
Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects
Westerbacka J; Cornér A; Kannisto K; Kolak M; Makkonen J; Korsheninnikova E; Nyman T; Hamsten A; Fisher RM; Yki-Järvinen H
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2005;25(12):2580-2586
Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome
Sjogren P; Basu S; Rosell M; Silveira A; de Faire U; Vessby B; Hamsten A; Hellenius ML; Fisher RM
Article: DIABETOLOGIA. 2004;47(6):1118-1125
Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance
Gertow K; Pietiläinen KH; Yki-Järvinen H; Kaprio J; Rissanen A; Eriksson P; Hamsten A; Fisher RM
Article: AMERICAN JOURNAL OF PHYSIOLOGY - ENDOCRINOLOGY AND METABOLISM. 2004;286(6):E941-E949
Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy
Sutinen J; Kannisto K; Korsheninnikova E; Fisher RM; Ehrenborg E; Nyman T; Virkamäki A; Funahashi T; Matsuzawa Y; Vidal H; Hamsten A; Yki-Järvinen H
Article: ENDOCRINOLOGY. 2004;145(4):1972-1979
Female-predominant expression of fatty acid translocase/CD36 in rat and human liver
Ståhlberg N; Rico-Bautista E; Fisher RM; Wu XX; Cheung L; Flores-Morales A; Tybring G; Norstedt G; Tollet-Egnell P
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2004;89(1):392-399
Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome
Gertow K; Bellanda M; Eriksson P; Boquist S; Hamsten A; Sunnerhagen M; Fisher RM
Article: AIDS. 2003;17(12):1753-1762
Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy
Kannisto K; Sutinen J; Korsheninnikova E; Fisher RM; Ehrenborg E; Gertow K; Virkamäki A; Nyman T; Vidal H; Hamsten A; Yki-Järvinen H
Article: ATHEROSCLEROSIS. 2003;167(2):311-317
Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men
Skoglund-Andersson C; Ehrenborg E; Fisher RM; Olivercrona G; Hamsten A; Karpe F
Article: ATHEROSCLEROSIS. 2003;167(2):265-273
A common polymorphism in the fatty acid transport protein-1 gene associated with elevated post-prandial lipaemia and alterations in LDL particle size distribution
Gertow K; Skoglund-Andersson C; Eriksson P; Boquist S; Orth-Gomér K; Schenck-Gustafsson K; Hamsten A; Fisher RM
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2003;23(4):688-694
Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy
Yki-Järvinen H; Sutinen J; Silveira A; Korsheninnikova E; Fisher RM; Kannisto K; Ehrenborg E; Eriksson P; Hamsten A
Article: ATHEROSCLEROSIS. 2003;166(2):243-251
Enhanced bridging function and augmented monocyte adhesion by lipoprotein lipase N9: insights into increased risk of coronary artery disease in N9 carriers
Fisher RM; Benhizia F; Schreiber R; Makoveichuk E; Putt W; Al-Haideri M; Deckelbaum RJ; Olivecrona G; Humphries SE; Talmud PJ
Article: MOLECULAR AND CELLULAR BIOCHEMISTRY. 2002;239(1-2):95-100
Fatty acid binding protein expression in different human adipose tissue depots in relation to rates of lipolysis and insulin concentration in obese individuals
Fisher RM; Thörne A; Hamsten A; Arner P
Article: INTERNATIONAL JOURNAL OF OBESITY. 2002;26(10):1379-1385
Effects of obesity and weight loss on the expression of proteins involved in fatty acid metabolism in human adipose tissue
Fisher RM; Hoffstedt J; Hotamisligil GS; Thörne A; Rydén M
Article: DIABETOLOGIA. 2001;44(10):1268-1273
Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals
Fisher RM; Eriksson P; Hoffstedt J; Hotamisligil GS; Thörne A; Rydén M; Hamsten A; Arner P
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2000;20(12):2663-2669
Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men
Waterworth DM; Talmud PJ; Bujac SR; Fisher RM; Miller GJ; Humphries SE
Article: ATHEROSCLEROSIS. 2000;149(2):387-394
Genetic factors associated with response of LDL subfractions to change in the nature of dietary fat
Wallace AJ; Humphries SE; Fisher RM; Mann JI; Chisholm A; Sutherland WHF
Article: JOURNAL OF LIPID RESEARCH. 1999;40(2):287-294
Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II
Fisher RM; Burke H; Nicaud V; Ehnholm C; Humphries SE
Article: CIRCULATION. 1997;96(3):733-740
Lipoprotein lipase variants D9N and N291S, are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations - Studies in the fasting and postprandial states: The European atherosclerosis research studies
Gerdes C; Fisher RM; Nicaud V; Boer J; Humphries SE; Talmud PJ; Faergeman O
Article: JOURNAL OF LIPID RESEARCH. 1997;38(7):1463-1472
Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol
Syvanne M; Talmud PJ; Humphries SE; Fisher RM; Rosseneu M; Hilden H; Taskinen MR
Article: METABOLISM: CLINICAL AND EXPERIMENTAL. 1997;46(6):605-610
Very-low-density lipoprotein subfraction composition and metabolism by adipose tissue
Fisher RM; Miles JM; Kottke BA; Frayn KN; Coppack SW
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1996;26(8):631-639
Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia
DeBruin TWA; Mailly F; VanBarlingen HHJJ; Fisher R; Cabezas MC; Talmud P; DallingaThie GM; Humphries SE
Article: CLINICAL SCIENCE. 1996;90(5):409-415
Carbohydrate metabolism in insulin resistance: Glucose uptake and lactate production by adipose and forearm tissues in vivo before and after a mixed meal
Coppack SW; Fisher RM; Humphreys SM; Clark ML; Pointon JJ; Frayn KN
Article: ATHEROSCLEROSIS. 1996;122(1):21-28
Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study
Mailly F; Fisher RM; Nicaud V; Luong LA; Evans AE; MarquesVidal P; Luc G; Arveiler D; Bard JM; Poirier O; Talmud PJ; Humphries SE
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1996;270(4):E718-E722
Periprandial systemic and regional lipase activity in normal humans
Coppack SW; Yost TJ; Fisher RM; Eckel RH; Miles JM
Article: JOURNAL OF LIPID RESEARCH. 1995;36(10):2104-2112
INTERACTION OF THE LIPOPROTEIN-LIPASE ASPARAGINE-291-]SERINE MUTATION WITH BODY-MASS INDEX DETERMINES ELEVATED PLASMA TRIACYLGLYCEROL CONCENTRATIONS - A STUDY IN HYPERLIPIDEMIC SUBJECTS, MYOCARDIAL-INFARCTION SURVIVORS, AND HEALTHY-ADULTS
FISHER RM; MAILLY F; PEACOCK RE; HAMSTEN A; SEED M; YUDKIN JS; BEISIEGEL U; FEUSSNER G; MILLER G; HUMPHRIES SE; TALMUD PJ
Article: CLINICA CHIMICA ACTA. 1995;236(1):7-17
HUMAN TRIACYLGLYCEROL-RICH LIPOPROTEIN SUBFRACTIONS AS SUBSTRATES FOR LIPOPROTEIN-LIPASE
FISHER RM; COPPACK SW; HUMPHREYS SM; GIBBONS GF; FRAYN KN
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1995;268(4):E588-E594
IMPAIRED POSTPRANDIAL CLEARANCE OF TRIACYLGLYCEROL-RICH LIPOPROTEINS IN ADIPOSE-TISSUE IN OBESE SUBJECTS
POTTS JL; COPPACK SW; FISHER RM; HUMPHREYS SM; GIBBONS GF; FRAYN KN
Visa fler

Alla övriga publikationer

Review: OBESITY REVIEWS. 2022;23(4):e13403
The multifaceted roles of the adipose tissue vasculature
Ioannidou A; Fisher RM; Hagberg CE
Preprint: BIORXIV. 2021
Hypertrophied human adipocyte spheroids asin vitromodel of weight gain and adipose tissue dysfunction
Ioannidou A; Alatar S; Åhlander M; Hornell A; Fisher R; Hagberg C
Editorial comment: ATHEROSCLEROSIS. 2013;226(2):510-516
European Lipoprotein Club: Report of the 35th ELC Annual Conference (Tutzing, 10th-13th September 2012)
Costet P; Ehrenborg E; Fisher R; Fielding B; Groen A; Kardassis D; Malle E; Mulder M; Niemeier A; Norata GD; Hansen AT; von Eckardstein A
Other: ATHEROSCLEROSIS. 2012;221(1):287-293
European Lipoprotein Club: Report of the 34th ELC annual conference, Tutzing, 5-8 September 2011.
Bernini F; Costet P; Ehrenborg E; Fisher R; Fielding B; Freeman D; Groen A; Malle E; Mulder M; Niemeier A; Hansen AT; von Eckardstein A
Editorial comment: ATHEROSCLEROSIS. 2011;215(1):249-255
Report of the 33rd Annual Conference of the European Lipoprotein Club, Tutzing, 6-9 September 2010
Bernini F; Fisher R; Freeman D; Groen A; Kalopissis A; Malle E; Mulder M; Niemeier A; Parini P; Hansen AT; von Eckardstein A
Published conference paper: JOURNAL OF CARDIOVASCULAR RISK. 2009;16(1):80-84
Beneficial effects of individualized physical activity on prescription on body composition and cardiometabolic risk factors: results from a randomized controlled trial
Kallings LV; Johnson JS; Fisher RM; de Faire U; Stahle A; Hemmingsson E; Hellenius M-L
Editorial comment: NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE. 2008;5(1):18-19
Is it time to discard the apo B:apo A-I ratio as a predictor of cardiovascular disease?
Sierra-Johnson J; Fisher RM
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):39
High apolipoprotein B/apolipoprotein ai ratio is associated with insulin resistance in US non-diabetic subjects
Sierra-Johnson J; Romero-Corral A; Fisher RM; Lopez-Jimenez F; Somers VK
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):116
Endothelial activity is related to diet and components of the metabolic syndrome, but not to advanced glycation end-products in healthy swedish men
Sjogren P; Basta G; de Caterina R; Rosell M; Basu S; Silveira A; de Faire U; Vessby B; Hamsten A; Hellenius ML; Fisher RM
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):3
Stearoyl coa desaturase (SCD) activity in human adipose tissue is increased in the metabolic syndrome
Fisher RM; Sjogren P; Rose M; Hamsten A; Vessby B; Hellenius M-L
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):60-61
Human evidence for the involvement of INSIG-2 in the adipose tissue metabolism
Krapivner S; Popov S; Chemogubova E; Hellenius M-L; Fisher R; Hamsten A; van't Hooft F
Letter: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2006;26(4):E31-E32
Oxidized LDL and the metabolic syndrome - In response
Sjogren P; Hamsten A; Hellenius ML; Fisher RM
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):231
Relationships between autoantibodies against modified LDL and advanced glycation end-products in clinically healthy men
Sjögren P; Fredrikson GN; Basta G; Hamsten A; Nilsson J; Hellenius ML; De Caterina R; Fisher RM
Review: CURRENT OPINION IN LIPIDOLOGY. 2005;16(2):173-178
Fatty acid transport proteins and insulin resistance
Fisher RM; Gertow K
Published conference paper: JOURNAL OF NUTRITION. 2004;134(7):1729-1735
Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men
Sjogren P; Rosell M; Skoglund-Andersson C; Zdravkovic S; Vessby B; de Faire U; Hamsten A; Hellenius ML; Fisher RM
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2003;4(2):48-49
Genetic and structural evaluation of fatty acid transport protein-4 (FATP4) in relation to markers of the insulin resistance syndrome
Gertow K; Bellanda M; Sunnerhagen M; Eriksson P; Boquist S; Hamsten A; Fisher R
Review: ATHEROSCLEROSIS. 1997;135(2):145-159
Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis
Fisher RM; Humphries SE; Talmud PJ

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI